Indivior Pharmaceuticals INDV
NASDAQ INDV
$36.59 -0.29 (-0.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Indivior Pharmaceuticals (INDV) EV to EBITDA (2024 - 2026)

Updated

Indivior Pharmaceuticals' (INDV) EV to EBITDA came in at 10.74 for Q2 2026, up 88.4% from 5.70 a year earlier and up 3.8% from the prior quarter.

Analysis

Indivior Pharmaceuticals (INDV) EV to EBITDA (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to EBITDA at Indivior Pharmaceuticals was 8.85, up 811.9% year-over-year; for FY2025, it was 15.78, down 30.7% from FY2024.

  • In prior years, Indivior Pharmaceuticals' EV to EBITDA was 22.77 in FY2024 and 6.19 in FY2021.
  • Quarterly EV to EBITDA has run from a low of 5.70 in Q2 2025 to a high of 22.77 in Q4 2024 over five years.
  • According to Business Quant data, EV to EBITDA for the three prior quarters was 10.35 (Q1 2026), 15.78 (Q4 2025) and 10.69 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Indivior Pharmaceuticals 4.35 Bn 3.32 Bn 294.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.74
Mar 31, 2026 10.35
Dec 31, 2025 15.78
Sep 30, 2025 10.69
Jun 30, 2025 5.70
Mar 31, 2025 18.98
Dec 31, 2024 22.77
API Access

Indivior Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=INDV&period=max&api_key=YOUR_API_KEY